IL12RB2
Interleukin-12 receptor subunit beta-2
Also known as: I12R2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99665
- Gene
- IL12RB2
- Ensembl
- ENSG00000081985
- Chromosome
- 1
- Canonical length
- 862 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]
Canonical amino-acid sequenceUniProt
862 residues, UniProt reviewed canonical sequence.
>Q99665|IL12RB2
1 MAHTFRGCSL AFMFIITWLL IKAKIDACKR GDVTVKPSHV ILLGSTVNIT CSLKPRQGCF
61 HYSRRNKLIL YKFDRRINFH HGHSLNSQVT GLPLGTTLFV CKLACINSDE IQICGAEIFV
121 GVAPEQPQNL SCIQKGEQGT VACTWERGRD THLYTEYTLQ LSGPKNLTWQ KQCKDIYCDY
181 LDFGINLTPE SPESNFTAKV TAVNSLGSSS SLPSTFTFLD IVRPLPPWDI RIKFQKASVS
241 RCTLYWRDEG LVLLNRLRYR PSNSRLWNMV NVTKAKGRHD LLDLKPFTEY EFQISSKLHL
301 YKGSWSDWSE SLRAQTPEEE PTGMLDVWYM KRHIDYSRQQ ISLFWKNLSV SEARGKILHY
361 QVTLQELTGG KAMTQNITGH TSWTTVIPRT GNWAVAVSAA NSKGSSLPTR INIMNLCEAG
421 LLAPRQVSAN SEGMDNILVT WQPPRKDPSA VQEYVVEWRE LHPGGDTQVP LNWLRSRPYN
481 VSALISENIK SYICYEIRVY ALSGDQGGCS SILGNSKHKA PLSGPHINAI TEEKGSILIS
541 WNSIPVQEQM GCLLHYRIYW KERDSNSQPQ LCEIPYRVSQ NSHPINSLQP RVTYVLWMTA
601 LTAAGESSHG NEREFCLQGK ANWMAFVAPS ICIAIIMVGI FSTHYFQQKV FVLLAALRPQ
661 WCSREIPDPA NSTCAKKYPI AEEKTQLPLD RLLIDWPTPE DPEPLVISEV LHQVTPVFRH
721 PPCSNWPQRE KGIQGHQASE KDMMHSASSP PPPRALQAES RQLVDLYKVL ESRGSDPKPE
781 NPACPWTVLP AGDLPTHDGY LPSNIDDLPS HEAPLADSLE ELEPQHISLS VFPSSSLHPL
841 TFSCGDKLTL DQLKMRCDSL MLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL12RB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 6.2 nTPM
Expression across tissuesHPA
Tissue
- placenta: 6.2 nTPM
- skeletal muscle: 3.3 nTPM
- pancreas: 2.6 nTPM
- cerebral cortex: 1.9 nTPM
- adipose tissue: 1.7 nTPM
- lymph node: 1.5 nTPM
Single-cell type
- nk-cells: 356 nCPM
- myonuclei: 142 nCPM
- t-cells: 136 nCPM
- epicardial cells: 116 nCPM
- hematopoietic stem cells: 105 nCPM
- innate lymphoid cells: 85 nCPM
Immune cell
- NK-cell: 16 nTPM
- gdT-cell: 4.8 nTPM
- T-reg: 2.5 nTPM
- MAIT T-cell: 2 nTPM
- memory CD4 T-cell: 1.1 nTPM
- total PBMC: 0.8 nTPM
Brain region
- hippocampal formation: 10 nTPM
- cerebral cortex: 7 nTPM
- basal ganglia: 5.2 nTPM
- white matter: 4.2 nTPM
- midbrain: 3.9 nTPM
- thalamus: 2.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL12RB2.
Disease | ImmuneIEDB
Conditions an epitope on IL12RB2 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- cytokine-mediated signaling pathway
- interleukin-12-mediated signaling pathway
- positive regulation of cell population proliferation
- positive regulation of type II interferon production
- response to lipopolysaccharide
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL12RB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL12RB2 as an antibody target. Whether an autoantibody or antibody against IL12RB2 could matter depends on whether native IL12RB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL12RB2 is annotated at the cell surface, where native IL12RB2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL12RB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...